2024-11-14T14:51:58-06:00 2023-12-31 873707167 CBIZ MARKS PANETH LLC 4 CAMPUS DRIVE SUITE 200 PARSIPPANY NJ 07054 990 2023-01-01 201082179 ALZHEIMER'S DRUG DISCOVERY FOUNDATION ALZH 2129018000 57 WEST 57TH ST 904 NEW YORK NY 10019 HOWARD FILLIT MD FOUNDING EXEC. DIR. 2129018000 2024-11-12 1 1 MAGDALENA CZERNIAWSKI P00535099 9732671400 2024-11-12 2023 2024-10-15 13:58:12Z HOWARD FILLIT MD 57 WEST 57TH ST 904 NEW YORK NY 10019 494090424 0 X WWW.ALZDISCOVERY.ORG X 2004 DE ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. 23 22 47 22 0 0 249842003 30595495 6425669 4205157 -2054312 3119933 -186255 -178565 254027105 37742020 29455921 47673524 0 0 3990433 8326107 0 0 4049179 3396547 5943957 36842901 61943588 217184204 -24201568 340253841 324173528 56741667 64182947 283512174 259990581 ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. 0 0 55585427 47673524 4205157 THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION IS DEDICATED TO RAPIDLY ACCELERATING THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. THE ADDF IS SOLELY FOCUSED ON FUNDING THE DEVELOPMENT OF DRUGS FOR ALZHEIMER'S, EMPLOYING A VENTURE PHILANTHROPY MODEL TO SUPPORT RESEARCH IN ACADEMIA AND THE BIOTECH INDUSTRY. 55585427 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 58 0 1 47 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 23 22 1 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY AL AR CA CT FL GA HI IL KS KY MA MD MI MN MS NC ND NH NJ NM OR PA RI SC TN UT VA WI WV X KAREN HARRIS CFO 2129018000 57 WEST 57TH ST 904 NEW YORK NY 10019 ALICE SHURE GOVERNOR 1.00 X 0 0 0 BEATRIZ ILLESCAS PUTZEYS-CLAUGUS GOVERNOR 1.00 X 0 0 0 BONNIE PFEIFER EVANS GOVERNOR 1.00 X 0 0 0 DAVID WEINREB GOVERNOR 1.00 X 0 0 0 GARY M LAUDER GOVERNOR 1.00 X 0 0 0 HOWARD FILLIT MD FOUNDING EXEC. DIR. & CHIEF SCI. OFF. 40.00 X X 632502 0 32404 LANNY EDELSOHN MD GOVERNOR 1.00 X 0 0 0 LAURENCE LEEDS JR GOVERNOR 1.00 X 0 0 0 LEONARD LAUDER CO-CHAIRMAN /GOVERNOR 1.00 X X 0 0 0 MELVIN GOODES HONORARY GOVERNOR 1.00 X 0 0 0 MIIA KIVIPELTO MD PHD GOVERNOR 1.00 X 0 0 0 NANCY CORZINE GOVERNOR 1.00 X 0 0 0 NANCY GOODES GOVERNOR 1.00 X 0 0 0 PAULA ZAHN GOVERNOR 1.00 X 0 0 0 RANDAL SANDLER CO-VICE CHAIRMAN & SECRETARY 1.00 X X 0 0 0 RICHARD MOHS PHD GOVERNOR 1.00 X 0 0 0 ROBERT BELFER GOVERNOR 1.00 X 0 0 0 ROBERTA DIAZ BRINTON PHD GOVERNOR 1.00 X 0 0 0 RONALD LAUDER CO-CHAIRMAN /GOVERNOR 1.00 X X 0 0 0 SANDRA DAY O'CONNOR HONORARY CHAIRMAN 1.00 X 0 0 0 SHARON SAGER GOVERNOR 1.00 X 0 0 0 THOMAS MCWILLIAMS CO-VICE CHAIRMAN & TREASUR 1.00 X X 0 0 0 THOMAS SMITH JR GOVERNOR 1.00 X 0 0 0 KAREN HARRIS CFO AND HEAD OF MISSION 40.00 X 366749 0 24726 MARK ROITHMAYR CEO 40.00 X 619606 0 39387 AARON BURSTEIN HEAD OF SEARCH AND EVALUATION 40.00 X 301736 0 48360 CHRISTOPHER CARLSON DIRECTOR, SEARCH & EVALUATION 40.00 X 182770 0 30842 JANE MCINTOSH CHIEF EXTERNAL AFFAIRS 40.00 X 359470 0 12350 LAKITA CAVIN ATTORNEY, MISSION-RELATED INVESTMENTS 40.00 X 208205 0 21418 LAURA NISENBAUM EXECUTIVE DIRECTOR, DRUG DEV. 40.00 X 434157 0 32393 3105195 0 241880 19 0 1 0 MORGAN LEWIS & BOCKIUS LLP 1701 MARKET STREET PHILADELPHIA PA 19103 LEGAL SERVICES 917588 1 5895178 24700317 19713217 30595495 PRI INCOME 900099 4205157 4205157 4205157 3119289 3119289 455706533 455705889 644 644 644 463950 5895178 642515 -178565 -178565 37742020 4205157 0 2941368 35679288 35679288 11994236 11994236 1715374 1123649 360486 231239 4767011 2700852 688693 1377466 586556 346125 89662 150769 834099 486752 132115 215232 423067 249313 68044 105710 1098725 1098725 85189 85189 1144070 499148 324887 320035 573425 318038 96398 158989 82852 27567 36908 18377 129072 42946 57497 28629 390662 188657 95525 106480 732283 588502 36553 107228 43675 43675 OTHER FUNDRAISING EXPEN 986920 986920 PUBLIC RELATIONS 420744 156337 79160 185247 MISCELLANEOUS 256340 85292 114190 56858 61943588 55585427 2308982 4049179 1660731 418639 45203944 39796956 213144667 188735033 270603 403557 726033 568226 160061 157807 77192847 92342872 2620988 2318664 340253841 324173528 2594953 2790497 50849708 58002921 637024 1034282 2659982 2355247 56741667 64182947 X 61551323 74577885 221960851 185412696 283512174 259990581 340253841 324173528 -24201568 679975 0 X X 0 1 X 1 0 X 17497049 21163991 41612740 249842003 30595495 360711278 17497049 21163991 41612740 249842003 30595495 360711278 237485572 123225706 948041 1230614 206491 857675 3119289 6362110 3089809 922871 2821986 291055 463950 7589671 374663059 26940242 0.32890 0.33390 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING INCOME - 2019 AMOUNT: $ 3,089,809. 2020 AMOUNT: $ 922,871. 2021 AMOUNT: $ 2,821,986. 2022 AMOUNT: $ 291,055. 2023 AMOUNT: $ 463,950. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 547493 389686 157807 178540 178540 0 157807 OPERATING LEASE LIABILITY 2355247 2355247 X 38192745 679975 -144061 535914 37656831 85189 85189 37742020 61714338 0 61714338 85189 144061 229250 61943588 PART X, LINE 2: THE FOUNDATION BELIEVES IT HAS NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2023 AND 2022, IN ACCORDANCE WITH ASC TOPIC 740, INCOME TAXES, WHICH PROVIDES STANDARDS FOR ESTABLISHING AND CLASSIFYING ANY TAX PROVISIONS FOR UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INDIRECT FUNDRAISING EXPENSES -144,061. PART XII, LINE 4B - OTHER ADJUSTMENTS: INDIRECT FUNDRAISING EXPENSE 144,061. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 9609032 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 1785204 EAST ASIA AND THE PACIFIC GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 600000 0 0 0 0 0 0 11994236 0 11994236 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, RESEARCH 600000 ELECTRONIC 0 NORTH AMERICA RESEARCH 599811 ELECTRONIC 0 NORTH AMERICA RESEARCH 815393 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 25000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 208018 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 150000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 278998 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 450000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 4262019 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 689394 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 1886057 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 381695 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 584817 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 185022 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 245313 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 262699 ELECTRONIC 0 NORTH AMERICA RESEARCH 100000 ELECTRONIC 0 NORTH AMERICA RESEARCH 270000 ELECTRONIC 0 1 17 0 0 0 0 0 0 CONNOISEURS DINNER 2452075 2339050 113025 6110 167222 PALM BEACH 1335350 1255930 79420 8419 63463 4 2571703 2300198 271505 22200 375101 6359128 5895178 463950 36729 605786 642515 -178565 1 ALZPATH INC 2292 FARADAY AVENUE CARLSBAD CA 92008 851378458 1910202 0 ALZHEIMERS RESEARCH AMERICAN NEUROLOGICAL ASSOCIATION 1120 ROUTE 73 SUITE 200 MOUNT LAUREL NJ 08054 411488447 501(C)(3) 10000 0 ALZHEIMERS RESEARCH AMPRION INC 149 NEW MONTGOMERY ST FLOOR 4 SAN FRANCISCO CA 94105 261195143 570750 0 ALZHEIMERS RESEARCH APRINOIA THERAPEUTICS INC 245 MAIN ST CAMBRIDGE MA 02142 863658862 4357900 0 ALZHEIMERS RESEARCH ASTROCYTE PHARMACEUTICALS INC 93 SHENNECOSSETT ROAD GROTON CT 06340 471533962 1000000 0 ALZHEIMERS RESEARCH BIOTECHNOLOGY INNOVATION ORGANIZATION 1201 NEW YORK AVENUE NW SUITE 1300 WASHINGTON DC 20005 521224577 501(C)(6) 73700 0 ALZHEIMERS RESEARCH BRAINSCOPE COMPANY INC 4350 EAST-WEST HIGHWAY 10TH FL BETHESDA MD 20814 204916707 491086 0 ALZHEIMERS RESEARCH CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 441064962 341018992 501(C)(3) 599259 0 ALZHEIMERS RESEARCH CICARDIC LLC 27 BARTLETT AVE ARLINGTON MA 02476 812556740 675890 0 ALZHEIMERS RESEARCH CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501(C)(3) 1828343 0 ALZHEIMERS RESEARCH CURASEN THERAPEUTICS INC 930 BRITTAN ROAD SUITE 306 SAN CARLOS CA 94070 812270808 5814712 0 ALZHEIMERS RESEARCH DAVOS ALZHEIMERS COLLABORATIVE 155 LANCASTER AVE PHILADELPHIA PA 19087 861884515 501(C)(3) 2500000 0 ALZHEIMERS RESEARCH FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH 11400 ROCKVILLE PIKE SUITE 600 NORTH BETHESDA MD 20852 521986675 501(C)(3) 30000 0 ALZHEIMERS RESEARCH GLOBAL ALZHEIMERS PLATFORM 1101 K STREET NW SUITE 400 WASHINGTON DC 20005 473290570 501(C)(3) 30000 0 ALZHEIMERS RESEARCH METRO INTERNATIONAL BIOTECH 500 TECHNOLOGY SQUARE SUITE 590 CAMBRIDGE MA 02139 465328762 501(C)(3) 5750000 0 ALZHEIMERS RESEARCH MILKEN INSTITUTE 2711 S LOOP DR AMES IA 50010 421471592 501(C)(3) 250000 0 CONFERENCE SPONSORSHIP NEURODEX 4 STRATHMORE ROAD NATICK MA 01760 831644694 750000 0 ALZHEIMERS RESEARCH PELAGOS PHARMACEUTICALS 790 MEMORIAL DRIVE CAMBRIDGE MA 02139 371923444 214118 0 ALZHEIMERS RESEARCH STARTUP HEALTH LLC 2000 BROADWAY 18TH FLOOR NEW YORK NY 10023 454362441 975875 0 ALZHEIMERS RESEARCH THERINI BIO 1650 OWENS ST SAN FRANCISCO CA 94158 814579978 5000000 0 ALZHEIMERS RESEARCH TRUSTEES OF BOSTON UNIVERSITY ONE SILBER WAY BOSTON MA 02215 042103547 501(C)(3) 844286 0 ALZHEIMERS RESEARCH TUFTS MEDICAL CENTER 800 WASHINGTON STREET BOSTON MA 02111 043400617 501(C)(3) 599788 0 ALZHEIMERS RESEARCH UNIVERSITY OF CALIFORNIA IRVINE 260 ALDRICH HALL IRVINE CA 926971075 952226406 175000 0 ALZHEIMERS RESEARCH USAGAINSTALZHEIMER'S 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 200152604 450672514 501(C)(3) 35000 0 ALZHEIMERS RESEARCH VIRGINIA COMMONWEALTH UNIVERSITY 1001 WEST MAIN STREET RICHMOND VA 232842006 546001758 600000 0 ALZHEIMERS RESEARCH WAKE FOREST UNIVERSITY WAKE FOREST ROAD WINSTON SALEM NC 27157 560532138 501(C)(3) 589379 0 ALZHEIMERS RESEARCH 14 13 PART I, LINE 2: GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS, AS WELL AS, AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS FOR ALL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MID-YEAR AND END-OF-YEAR PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVERNORS PERIODICALLY. SOME OF THE GRANTS LISTED IN PART II OF THIS SCHEDULE I ARE GRANTS WITH A "PARTICIPATING INTEREST," WHICH ENTITLE THE FOUNDATION TO RECEIVE, IN THE EVENT THAT THE FUNDED PROJECT IS LICENSED OR OTHERWISE COMMERCIALIZED, A PERCENTAGE OF THE LICENSING OR OTHER REVENUE THAT THE GRANTEE ORGANIZATION RECEIVES OR EQUITY IN THE RESULTING BUSINESS ENTITY. X X X X 0 0 0 0 0 0 0 1 0 HOWARD FILLIT MD FOUNDING EXEC. DIR. & CHIEF SCI. OFF 616014 0 0 0 16488 0 6082 0 26322 0 664906 0 0 0 MARK ROITHMAYR CEO 616438 0 0 0 3168 0 13200 0 26187 0 658993 0 0 0 LAURA NISENBAUM EXECUTIVE DIRECTOR, DRUG DEV. 430989 0 0 0 3168 0 13200 0 19193 0 466550 0 0 0 KAREN HARRIS CFO AND HEAD OF MISSION 333581 0 30000 0 3168 0 13200 0 11526 0 391475 0 0 0 JANE MCINTOSH CHIEF EXTERNAL AFFAIRS 358750 0 0 0 720 0 12350 0 0 0 371820 0 0 0 AARON BURSTEIN HEAD OF SEARCH AND EVALUATION 299672 0 0 0 2064 0 12300 0 36060 0 350096 0 0 0 LAKITA CAVIN ATTORNEY, MISSION-RELATED INVESTMENT 207101 0 0 0 1104 0 8446 0 12972 0 229623 0 0 0 CHRISTOPHER CARLSON DIRECTOR, SEARCH & EVALUATION 179776 0 0 0 2994 0 7380 0 23462 0 213612 0 0 0 PART I, LINE 7 THE BONUSES REPORTED IN PART II, COLUMN B(II) WERE APPROVED BY THE CEO. X 21 19713217 FMV 0 1 0 PART I, COLUMN (B): THE NUMBER IN COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTIONS. PART I, LINE 32B: IT IS ADDF'S POLICY TO MAINTAIN APPROPRIATE BUSINESS RELATIONSHIPS WITH REGARD TO GIVING AND RECEIVING CORPORATE GIFTS. EMPLOYEES SHOULD USE GOOD JUDGMENT WHEN ENTERTAINING CUSTOMERS AND BUSINESS PARTNERS AND SUCH ENTERTAINMENT SHOULD NOT EXCEED TYPICAL MEAL AND ASSOCIATED EXPENSES. EMPLOYEE SHOULD DISCOURAGE OTHERS FROM OFFERING EXTRAVAGANT MEALS OR ENTERTAINMENT. SPECIAL CARE MUST BE TAKEN TO AVOID EVEN THE IMPRESSION OF A CONFLICT OF INTEREST. IF AN EMPLOYEE IS IN DOUBT ABOUT THE APPROPRIATENESS OF A PLANNED EVENT OR GIFT TO BE GIVEN ON BEHALF OF ADDF, CONTACT THE CHIEF OF STAFF OR THE CEO FORM 990, PART VI, SECTION A, LINE 1A THE FOUNDATION HAS A TWO CLASS BOARD STRUCTURE (CLASS A AND CLASS B) PURSUANT TO WHICH EACH CLASS A BOARD MEMBER IS ENTITLED TO ONE VOTE AND EACH CLASS B MEMBER IS ENTITLED TO ONE-HALF VOTE. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING FAMILY AND/OR BUSINESS RELATIONSHIPS EXIST AMONG GOVERNORS AND OFFICERS OF THE FOUNDATION: (I) LEONARD A. LAUDER AND RONALD S. LAUDER: FAMILY AND BUSINESS RELATIONSHIP; (II) LEONARD A. LAUDER, AND GARY M. LAUDER: BUSINESS AND FAMILY RELATIONSHIP; (III) LEONARD A.LAUDER, RONALD S. LAUDER AND DR. HOWARD FILLIT: BUSINESS RELATIONSHIP; (IV) ALICE SHURE AND BONNIE PFEIFER EVANS: FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 4 THE BY-LAWS WERE AMENDED DURING THE YEAR. SOME OF THE CHANGES ARE THE FORMATION OF A COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE COMPLETED FORM 990 IS REVIEWED BY THE FOUNDATION'S CHIEF FINANCIAL OFFICER, FINANCE DIRECTOR, AND THE ADDF FINANCE AND AUDIT COMMITTEE. THEN A COPY IS PROVIDED TO THE BOARD OF GOVERNORS AND THE FOUNDATION'S OFFICERS. THE FINAL FORM 990 IS SIGNED BY EITHER THE FOUNDATION'S FOUNDING EXECUTIVE DIRECTOR OR TREASURER. FORM 990, PART VI, SECTION B, LINE 12C AT LEAST ANNUALLY, CONFLICT OF INTEREST DISCLOURE STATEMENTS ARE CIRCULATED TO THE BOARD OF GOVERNORS AND OFFICERS FOR REVIEW AND COMPLETION. THE COMPLETED STATEMENTS ARE THEN REVIEWED UNDER THE SUPERVISION OF A FOUNDATION OFFICER. FORM 990, PART VI, SECTION B, LINE 15A IN 2021, THE ADDF ENGAGED A BENCHMARKING/SALARY ASSESSMENT CONSULTANT WHO ANALYZED ALL ROLES. THEY PROVIDED A FULL REPORT MARKET ANALYSIS ON THE CEO AND FOUNDING ED'S COMPENSATION, AND THE PRESENTATION WAS REVIEWED/SHARED WITH RANDAL SANDLER, CO-VICE CHAIR OF THE ADDF BOARD. ADDITIONALLY, THEIR PERFORMANCE AND SALARY IS REVIEWED ANNUALLY, ALONG WITH OTHER ADDF STAFF, BY RANDAL SANDLER. STARTING ON 2023, THEY HAVE ESTABLISHED THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART XII, LINCE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. INSTITUTE FOR THE STUDY OF AGING 57 WEST 57TH STREET NEW YORK NY 10019 134024149 GRANTS TO SUPPORT RESEARCH FOR COGNITIVE NY 501(C)(3) PF N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0